ROZLYTREK

Capsule, hard, 200mg
RxActive license

Active substance (INN)

entrectinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength200mg
PackagingUkupno 90 kapsula tvrdih u boci plastičnoj u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX14)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateOctober 27, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

ROZLYTREKRx
Capsule, hard, 100mgF. Hoffmann-La Roche AG
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026